Description
The p.V79I variant (also known as c.235G>A), located in coding exon 3 of the MYL3 gene, results from a G to A substitution at nucleotide position 235. The valine at codon 79 is replaced by isoleucine, an amino acid with highly similar properties. This variant was detected in an asymptomatic individual with hypertrophic cardiomyopathy (HCM), as well as in three family members with borderline HCM findings and in six unaffected carrier family members, including some who were children at the time of evaluation (Andersen PS et al. Biochem Res Int, 2012 Apr;2012:685108). This variant has also been reported as a secondary finding in exome cohorts with limited clinical details provided (Lawrence L et al. Genet Med, 2014 Oct;16:741-50; Olfson E et al. PLoS One, 2015 Sep;10:e0135193). This amino acid position is well conserved in available vertebrate species. In addition, the in silico prediction for this alteration is inconclusive. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear.
# | Sample | Method | Observation |
---|
Origin | Affected | Number tested | Tissue | Purpose | Method | Individuals | Allele frequency | Families | Co-occurrences |
---|
1 | germline | unknown | not provided | not provided | not provided | | not provided | not provided | not provided | not provided |